Condition
Postnatal Growth Restriction
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05515614Not ApplicableCompleted
Targeted Nutrition for Moderate to Late Preterm Infants
NCT05403684Not ApplicableCompletedPrimary
Impact of Hindmilk on Weight Gain Among Moderate to Very Preterm Infants in Zambia
NCT05228847Not ApplicableUnknownPrimary
Human Milk-derived Fortification in Preterm Infants
Showing all 3 trials